A novel µ-conopeptide, CnIIIC, exerts potent and preferential inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptors
Contributeurs/tricesFavreau, Philippe; Benoit, Evelyne; Hocking, Henry G; Carlier, Ludovic; D' hoedt, Dieter; Leipold, Enrico; Markgraf, René; Schlumberger, Sébastien; Córdova, Marco A; Gaertner, Hubert François; Paolini-Bertrand, Marianne; Hartley, Oliver; Tytgat, Jan; Heinemann, Stefan H; Bertrand, Daniel; Boelens, Rolf; Stocklin, Reto; Molgó, Jordi
Publié dansBritish journal of pharmacology, vol. 166, no. 5, p. 1654-1668
Date de publication2012
Résumé
Groupe de recherche
Citation (format ISO)
FAVREAU, Philippe et al. A novel µ-conopeptide, CnIIIC, exerts potent and preferential inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptors. In: British journal of pharmacology, 2012, vol. 166, n° 5, p. 1654–1668. doi: 10.1111/j.1476-5381.2012.01837.x
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:23511
- DOI : 10.1111/j.1476-5381.2012.01837.x
- PMID : 22229737
ISSN du journal0007-1188